|
?:authorAffiliation
|
-
[\'Virus and Immunity Unit, Department of Virology, Institut Pasteur, CNRS UMR 3569, Paris, France.\', \'Vaccine Research Institute, Creteil, France.\', \'Université de Paris, Sorbonne Paris Cité, Paris, France.\', \'Pathogen Discovery Laboratory, Department of Virology, Institut Pasteur, Paris, France.\', \'Laboratory of Humoral Immunology, Department of Immunology, Institut Pasteur, INSERM U1222, Paris, France.\', \'Molecular Genetics of RNA Viruses, Department of Virology, Institut Pasteur, CNRS UMR 3569, Paris, France.\', \'Université de Paris, Paris, France.\', \'Emerging Diseases Epidemiology Unit, Department of Global Health, Institut Pasteur, Paris, France.\', \'Department of Virology, Institut Pasteur, Paris, France.\', \'National Reference Center for Respiratory Viruses, Institut Pasteur, Paris, France.\', \'RNA Biology of Influenza Virus, Department of Virology, Institut Pasteur, Paris, France.\', \'Pasteur-TheraVectys joined unit, Institut Pasteur, Paris, France.\', \'Molecular Virology and Vaccinology Unit, Department of Virology, Institut Pasteur, Paris, France.\', \'Innovation lab: Vaccines, Institut Pasteur, Paris, France.\', \'Plate-Forme Technologique Production et Purification de Protéines Recombinantes, Institut Pasteur, Paris, France.\', \'Structural Virology Unit, Department of Virology, Institut Pasteur, CNRS UMR 3569, Paris, France.\', \'Université of Paris, INSERM UMR 1137 IAME, Paris, France.\', \'Medical and Infectious Diseases Intensive Care Unit, Assistance Publique-Hôpitaux de Paris, Bichat-Claude-Bernard University Hospital, Paris, France.\', \'Department of Virology, Assistance Publique-Hôpitaux de Paris, Bichat-Claude-Bernard University Hospital, Paris, France.\', \'Department of Infectious Diseases, Assistance Publique-Hôpitaux de Paris, Bichat-Claude-Bernard University Hospital, Paris, France.\', \'Department of Epidemiology, Biostatistics and Clinical Research, Assistance Publique-Hôpitaux de Paris, Bichat-Claude-Bernard University Hospital, INSERM CIC-EC 1425, Paris, France.\', \'Investigation Clinique et Accès aux Ressources Biologiques (ICAReB), Center for Translational Research, Institut Pasteur, Paris, France.\', \'Unité Coordination du Risque Epidémique et Biologique, AP-HP, Hôpital Necker, Paris, France.\', \'Etablissement Français du Sang (EFS), Paris, France.\', \'Service de maladies infectieuses, hôpital universitaire Cavale Blanche, Brest, France.\', \'CIC 1417, CIC de vaccinologie Cochin-Pasteur, AP-HP, Hôpital Cochin, Paris, France.\', \'Direction alerte et crises, réserve sanitaire, Santé publique France, Saint-Maurice, France.\', \'Centre d\'épidémiologie et de santé publique des armées, Marseille, France.\', \'Direction Générale de la Santé, Paris, France.\', \'PACRI Unit, Conservatoire National des Arts et Métiers, Paris, France.\', \'Direction de la recherche médicale, Institut Pasteur, Paris, France.\', \'Pathogen Discovery Laboratory, Department of Virology, Institut Pasteur, Paris, France. marc.eloit@pasteur.fr schwartz@pasteur.fr.\', \'National Veterinary School of Alfort, Maisons-Alfort, France.\', \'Virus and Immunity Unit, Department of Virology, Institut Pasteur, CNRS UMR 3569, Paris, France. marc.eloit@pasteur.fr schwartz@pasteur.fr.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}